These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 3703165)

  • 1. In vitro release of vasopressin and oxytocin from rat median eminence tissue.
    Verbalis JG; Baldwin EF; Ronnekleiv OK; Robinson AG
    Neuroendocrinology; 1986; 42(6):481-8. PubMed ID: 3703165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action.
    Spinedi E; Giacomini M; Jacquier MC; Gaillard RC
    Neuroendocrinology; 1991 Feb; 53(2):160-70. PubMed ID: 1849620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marked changes of arginine vasopressin, oxytocin, and corticotropin-releasing hormone in hypophysial portal plasma after pituitary stalk damage in the rat.
    Makara GB; Sutton S; Otto S; Plotsky PM
    Endocrinology; 1995 May; 136(5):1864-8. PubMed ID: 7720631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy.
    Plotsky PM; Sawchenko PE
    Endocrinology; 1987 Apr; 120(4):1361-9. PubMed ID: 3030697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin and CRF-ACTH in adrenalectomized and dexamethasone-treated rats.
    Hashimoto K; Yunoki S; Kageyama J; Ohno N; Takahara J; Ofuji T
    Neuroendocrinology; 1981 Feb; 32(2):87-91. PubMed ID: 6259547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of adrenalectomy and glucocorticoids on the peptides CRF-41, AVP and oxytocin in rat hypophysial portal blood.
    Fink G; Robinson IC; Tannahill LA
    J Physiol; 1988 Jul; 401():329-45. PubMed ID: 2845063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histaminergic and catecholaminergic interactions in the central regulation of vasopressin and oxytocin secretion.
    Knigge U; Willems E; Kjaer A; Jørgensen H; Warberg J
    Endocrinology; 1999 Aug; 140(8):3713-9. PubMed ID: 10433231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of the neurohypophysis in psychological stress].
    Scantamburlo G; Ansseau M; Legros JJ
    Encephale; 2001; 27(3):245-59. PubMed ID: 11488255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation.
    Hartman RD; Rosella-Dampman LM; Emmert SE; Summy-Long JY
    Endocrinology; 1986 Jul; 119(1):1-11. PubMed ID: 3720659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin-releasing factors (CRF) secreted by the rat median eminence in vitro in the presence or absence of ascorbic acid: quantitative role of vasopressin and catecholamines.
    Bény JL; Baertschi AJ
    Endocrinology; 1981 Sep; 109(3):813-7. PubMed ID: 6266808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GnRH release from the mediobasal hypothalamus. In vitro regulation by oxytocin.
    Gambacciani M; Yen SS; Rasmussen DD
    Neuroendocrinology; 1986; 42(2):181-3. PubMed ID: 3005897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predominant release of vasopressin vs. corticotropin-releasing factor from the isolated median eminence after adrenalectomy.
    Holmes MC; Antoni FA; Catt KJ; Aguilera G
    Neuroendocrinology; 1986; 43(2):245-51. PubMed ID: 3487744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotrophin-releasing peptides in rat hypophysial portal blood after paraventricular lesions: a marked reduction in the concentration of corticotrophin-releasing factor-41, but no change in vasopressin.
    Antoni FA; Fink G; Sheward WJ
    J Endocrinol; 1990 May; 125(2):175-83. PubMed ID: 2373973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forskolin-stimulated vasopressin and oxytocin release from the rat hypothalamo-neurohypophysial system in vitro is inhibited by melatonin.
    Roszczyk M; Juszczak M
    Endokrynol Pol; 2014; 65(2):125-31. PubMed ID: 24802736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural demonstration of oxytocin and vasopressin release sites in the neural lobe and median eminence of the rat by tannic acid and immunogold methods.
    Buma P; Nieuwenhuys R
    Neurosci Lett; 1987 Feb; 74(2):151-7. PubMed ID: 3574755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of vasopressin analgesia in rats treated neonatally with monosodium glutamate.
    Bodnar RJ; Truesdell LS; Nilaver G
    Peptides; 1985; 6(4):621-6. PubMed ID: 4070021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diethylstilbesterol- and pregnancy-induced changes in rat neurointermediate lobe oxytocin, arginine vasopressin, methionine enkephalin and dynorphin.
    Schriefer JA
    Neuroendocrinology; 1991 Sep; 54(3):185-91. PubMed ID: 1682832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid modulation of neuronal activity and hormone secretion induced by blood volume expansion.
    Ruginsk SG; Oliveira FR; Margatho LO; Vivas L; Elias LL; Antunes-Rodrigues J
    Exp Neurol; 2007 Aug; 206(2):192-200. PubMed ID: 17553493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in oxytocin and vasopressin secretion during sexual activity in men.
    Murphy MR; Seckl JR; Burton S; Checkley SA; Lightman SL
    J Clin Endocrinol Metab; 1987 Oct; 65(4):738-41. PubMed ID: 3654918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydration stimulates hypothalamic gene expression of histamine synthesis enzyme: importance for neuroendocrine regulation of vasopressin and oxytocin secretion.
    Kjaer A; Larsen PJ; Knigge U; Warberg J
    Endocrinology; 1995 May; 136(5):2189-97. PubMed ID: 7720668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.